In the present report, we demonstrate that both MKI and the PI3K inhibitor reduce levels of activated Rac1 in two medulloblastoma cell lines representing two molecularly defined medulloblastoma entities with high metastatic potential. This evidence concerns the gene RAC1 and medulloblastoma.